DUPONT DATA BOOK SCIENCE-BASED SOLUTIONS DuPont Investor Relations Contents 1 DuPont Overview 2 Corporate Financial Data Consolidated Income Statements Greg Friedman Tim Johnson Jennifer Driscoll Consolidated Balance Sheets Vice President Director Director Consolidated Statements of Cash Flows (302) 999-5504 (515) 535-2177 (302) 999-5510 6 DuPont Science & Technology 8 Business Segments Agriculture Electronics & Communications Industrial Biosciences Nutrition & Health Performance Materials Ann Giancristoforo Pat Esham Manager Specialist Safety & Protection (302) 999-5511 (302) 999-5513 20 Corporate Financial Data Segment Information The DuPont Data Book has been prepared to assist financial analysts, portfolio managers and others in Selected Additional Data understanding and evaluating the company. This book presents graphics, tabular and other statistical data about the consolidated company and its business segments. Inside Back Cover Forward-Looking Statements Board of Directors and This Data Book contains forward-looking statements which may be identified by their use of words like “plans,” “expects,” “will,” “believes,” “intends,” “estimates,” “anticipates” or other words of similar meaning. All DuPont Senior Leadership statements that address expectations or projections about the future, including statements about the company’s strategy for growth, product development, regulatory approval, market position, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures and financial results, are forward looking statements. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company’s control. Some of the important factors that could cause the company’s actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; ability to respond to market acceptance, rules, regulations and Individual Shareholder Relations: policies affecting products based on biotechnology; significant litigation and environmental matters; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or (302) 774-3033 political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, Main Office Number: weather events and natural disasters; ability to protect and enforce the company’s intellectual property rights; successful integration of acquired businesses and separation of underperforming or non-strategic assets or (302) 774-4994 businesses, including timely realization of the expected benefits from the separation of Perfomance Chemicals. The company undertakes no duty to update any forward-looking statements as a result of future developments Internet: www.dupont.com or new information. Use of Non-GAAP Measures As a supplement to DuPont financial results prepared in accordance with U.S. generally accepted accounting principles (GAAP), this Data Book presents non-GAAP measures. Consolidated company and segment results are shown on an operating earnings basis, which excludes significant items and non-operating pension and other postretirement employee benefit costs. Non-GAAP measures include but are not limited to operating earnings and operating earnings per share; operating earnings before interest, taxes, and noncontrolling interests (EBIT), as defined by the company; operating earnings before interest, taxes, noncontrolling interests, depreciation and amortization (EBITDA); and free cash flow. Non-GAAP measures are not a substitute for GAAP results. The company uses non-GAAP measures to evaluate and manage the company’s operations. The company believes that a discussion of operating results provides a useful analysis of ongoing operations. The determination of significant items may not be comparable to similarly titled measures used by other companies. This data should be read in conjunction with previously published company reports on Forms 10-K, 10-Q, and 8-K. These reports, along with reconciliations on non-GAAP measures to GAAP are available on the Investor Center of www.dupont.com. For complete details of significant items, see DuPont quarterly earnings news releases. The DuPont Data Book is available at www.dupont.com. September 2015 DuPont Overview The Data Book presents the historical financial information of DuPont from 2011 to 2014 restated to reflect the July 2015 spin-off of Chemours, the most significant step in our ongoing transformation to continue to deliver higher growth, higher value for shareholders. The results of Performance Chemicals are presented as discontinued operations We’re upgrading and modernizing everything from our management reporting and have been excluded from continuing operations, segment results, and related structures, to our manufacturing supply chains, to the way we process calculations in accordance with generally accepted accounting principles in the transactions. With a more streamlined organization, our investments will be United States (US GAAP). In addition, effective July 1, 2015, certain corporate targeted, disciplined, and effective, enhancing our competitive position in the expenses will now be included in segment operating earnings. Reclassifications marketplace. And we will continue to identify additional opportunities to reduce of prior year data have been made to conform to current year classifications. costs and streamline our organization. The results being reported today are further validation of DuPont’s strategy with DuPont’s ongoing business having delivered operating EPS compound annual Our Strategic Focus Areas growth of 13% between 2011 and 2014. Segment operating margins also improved Productivity, efficiency, and accountability continue to be ingrained in the next by 10%, approximately 200 basis points, when discontinued operations were generation DuPont. Our redesign will help us to continue to deliver on our cost excluded from the financial results. and value initiatives, and drive growth across our three strategic priorities: extending our leadership in agriculture and nutrition, strengthening and growing The decisive actions taken by the company have enabled us to continue to our advanced materials capabilities, and leveraging our science to develop a deliver volume, margin, and earnings growth in the majority of our segments in world leading bio-based industrial business. the period 2011–2014, although, like other companies in our industries, we have faced challenges in 2015 from currency and in agriculture markets. We remain • Agriculture & Nutrition: we’re making strategic investments to extend our focused on creating shareholder value by leveraging our advanced science and leadership in germplasm and breeding, while advancing our exciting biotech technology, market and value chain knowledge, global scale, and disciplined and crop protection pipelines to create valuable solutions for farmers. We’re management to bring integrated solutions to customers around the world. As we making excellent progress towards the commercialization of Leptra™ corn look ahead, we are intently focused on taking the actions necessary to capitalize hybrids in Brazil, Qrome™ corn products (previously identified as event DP fully on growth opportunities in each of our strategic focus areas, which will 4114), and several new technologies in Crop Protection. position DuPont for higher growth and higher value over the long term. • Advanced Materials: our application and product development investments in innovative polymer, electronic, and protective materials will help expand Highlights the performance boundaries in markets including automotive, aerospace, 2014 was a year of important progress as we continued to execute the strategic packaging, photovoltaics, and construction. transformation that is positioning next generation DuPont to deliver higher growth • Bio-based Industrials: we continue to ramp up our new products including and higher value for our shareholders. The significant milestones achieved in 2014 cold-water, bakery, and animal nutrition enzymes to build on our current include the ongoing refinement of our portfolio, with 10 strategic portfolio actions momentum. As innovation creates new demand for these products, we’re during the year, culminating in the spinoff of Chemours, the most significant step well-positioned to create new categories of renewably sourced bio-based in our transformation—which we completed in July 2015. Excluding Chemours, materials and fuels that draw on our knowledge from our agriculture and the portfolio actions in 2014 impacted sales by approximately $400 million. advanced materials business. Our transformation continued to be driven by innovation, execution, and global reach. Market relevance and integrated science remain true competitive Market-Driven Science Capabilities and Operations advantages that differentiate DuPont in the marketplace, and our powerful With greater emphasis than ever before on science-driven innovation, innovation pipeline continues